adenosine has been researched along with Adrenal Cortex Cancer in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Maksoud, MA; Almutairi, SM; Alshalani, AJ; Alturaiki, W; Aufy, M; Hameed, Y; Li, C; Li, H; Mahmoud, AM; Mubarak, A; Xu, W | 1 |
| Bi, J; Fu, Y; Kong, C; Sun, S; Yin, L | 1 |
| Cao, K; Chen, X; Cheng, Y; Gong, L; He, D; Hu, X; Jin, Y; Wang, Z; Xiao, M; Zhu, Y | 1 |
| Chong, T; Guan, Y; Ma, Y; Xu, F; Xue, L; Yang, X; Zhang, P | 1 |
| Assié, G; Batisse-Lignier, M; Bertherat, J; Djari, C; Drelon, C; Lefrançois-Martinez, AM; Martinez, A; Mathieu, M; Pointud, JC; Ragazzon, B; Rodriguez, S; Sahut-Barnola, I; Septier, A; Tabbal, H; Tauveron, I; Val, P | 1 |
5 other study(ies) available for adenosine and Adrenal Cortex Cancer
| Article | Year |
|---|---|
Elucidating the clinical and immunological value of m6A regulator-mediated methylation modification patterns in adrenocortical carcinoma.
Topics: Adenosine; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; DNA Copy Number Variations; Humans; Methylation; Tumor Microenvironment | 2023 |
Expression patterns and prognostic value of m6A RNA methylation regulators in adrenocortical carcinoma.
Topics: Adenosine; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Biomarkers, Tumor; Datasets as Topic; Down-Regulation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Methylation; Methyltransferases; Middle Aged; Oxidoreductases, N-Demethylating; Prognosis; RNA-Binding Proteins; RNA-Seq; RNA, Messenger; Survival Rate; Up-Regulation | 2021 |
Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
Topics: Adenosine; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Biomarkers, Tumor; Databases, Genetic; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Humans; MicroRNAs; Polymorphism, Single Nucleotide; Prognosis; Retrospective Studies; RNA, Long Noncoding; Tumor Microenvironment | 2021 |
Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
Topics: Adenosine; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Aged; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Computational Biology; Datasets as Topic; Disease Progression; Epigenesis, Genetic; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Heterogeneous-Nuclear Ribonucleoprotein Group C; Humans; Immune Checkpoint Inhibitors; Male; Methylation; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Nomograms; RNA; RNA-Binding Proteins; Survival Analysis; Survival Rate; Tumor Microenvironment | 2021 |
EZH2 cooperates with E2F1 to stimulate expression of genes involved in adrenocortical carcinoma aggressiveness.
Topics: Adenosine; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Animals; Cell Cycle Proteins; Cell Proliferation; Chromatin Immunoprecipitation; Computational Biology; E2F1 Transcription Factor; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Humans; Indoles; Mice, Knockout; Multivariate Analysis; Proportional Hazards Models; Ribonucleoside Diphosphate Reductase; Securin | 2019 |